AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks

If maintained until close, the decline would be the stock's biggest one-day percentage fall since the day of the 2024 U.S. presidential election.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。